Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery
- 1 January 2010
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 62 (1) , 55-61
Abstract
Objectives: The aim of this study was to test the ability of a colon targeting system comprising pellets film-coated with a dispersion of high amylose starch (Hylon VII) and ethylcellulose (Surelease) (1 : 2 w/w) to deliver a model drug (5-aminosalicylic acid; 5-ASA) in vivo into the colon of rabbits. An uncoated pellet formulation was used as a control.Methods: Six New Zealand female rabbits, approximately 2 kg, were randomly divided into two groups. Pellet formulations containing 50 mg/kg of 5-ASA were filled into hard gelatin capsules size 4, and were administered orally using a cannula. The rabbits were fasted for 12 h before, and throughout, the study but had free access to water. Blood samples were collected, through a catheter inserted into the marginal vein of the ear, at pre-determined times and the plasma analysed by a validated HPLC method with fluorescence detection.Results: Analysis of the 5-ASA plasma levels following administration of the uncoated pellets showed a Cmax of 2.38 ± 0.49 μg/ml at 2 h post administration confirming that this system released the drug at an unspecific site, most likely in the rabbits' stomach and proximal small intestine. On the other hand, the coated formulation showed a delayed drug absorption (Cmax 0.22 ± 0.19 μg/ml and tmax of 8 h), suggesting that the coating is able to prevent drug release in the stomach and small intestine, but allowing drug release in the colon. The coated pellets were retrieved from the rabbits' faeces after the 24-h study. They had a drug content of < 40%, suggesting that the film-coating had been digested by the bacterial amylases of the colon and the drug was released specifically in the colon of the rabbits.Conclusions: Results from this study showed that the proposed drug delivery system has the potential to deliver drugs specifically into the colon.Keywords
This publication has 31 references indexed in Scilit:
- Starch-based coatings for colon-specific delivery. Part II: Physicochemical properties and in vitro drug release from high amylose maize starch filmsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Starch-based coatings for colon-specific drug delivery. Part I: The influence of heat treatment on the physico-chemical properties of high amylose maize starchesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Biodistribution and pharmacokinetics of colon-specific HPMA copolymer–9-aminocamptothecin conjugate in miceJournal of Controlled Release, 2007
- In vitroevaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacinJournal of Drug Targeting, 2007
- Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat ColonJournal of Pharmaceutical Sciences, 1997
- Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pelletsJournal of Controlled Release, 1996
- Hydrogels for Site-Specific Drug Delivery to the Colon: In Vitro and in Vivo DegradationPharmaceutical Research, 1992
- Colon-Specific Delivery of Dexamethasone from a Glucoside Prodrug in the Guinea PigPharmaceutical Research, 1991
- Macromolecular prodrugs. XIV. Absorption characteristics of naproxen after oral administration of a dextran T-70-naproxen ester prodrug in pigsInternational Journal of Pharmaceutics, 1989
- THE MICROBIAL CONTRIBUTION TO HUMAN FAECAL MASSJournal of Medical Microbiology, 1980